☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Gastric Cancer
Unlocking Approval: Moitreyee Chatterjee-Kishore from Astellas & Kohei Shitara in Conversation with PharmaShots
June 24, 2024
Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...
February 2, 2022
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China
August 17, 2020
Celltrion and MSD Report Results of First-Line Triplet Regimen P-I/II PANTHERA trial in Patients with HER2-Positive Advanced Gastr...
May 27, 2020
Daiichi Sankyo and AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) Receive the US FDA's Orphan Drug Designation for Gastri...
May 22, 2020
Genialis Collaborates with Oncologie on Precision Medicine Initiative in Gastric Cancer
January 23, 2020
Load more...
Back to Home